Honestabe, you would be shocked if the pps went past $15? Why? When PPHM was set to move TNT for lung cancer treatment working with Dr. Epstein and Avid production for China demand was just being talked about the pps peaked around $4 pre split. When Imclone was showing success with Erbitux, their market capitalization exceeded $7 billion. That sort of market capitalization applied to PPHM spread across 50 million shares works out to be $140 pps. Even a more "reachable" $1 billion PPHM market capitalization translates to $20 pps.
Of course, PPHM needs to deliver on its business plan to bring about realization of that sort of share holder value. A good quarterly earnings report coupled with either word of renewed DTRA funding or positive trial results should be enough to get the pps into the $5 to $10 range. PPHM "should be enoughs" have a track record of disappointment. There is a lot that PPHM can release between now and the end of June that can make a big difference in the pps. I hope PPHM doesn't disappoint its long investors this time.
Best wishes and IMO.
KT